Background: The beneficial effects of endovascular treatment with new-generation
mechanical thrombectomy devices compared with intravenous thrombolysis alone to treat …

Object Mechanical thrombectomy is increasingly being used for the treatment of large-vessel
ischemic stroke in patients who arrive outside of the 3-hour tissue plasminogen activator …

Background In Ontario, current treatment for eligible patients who have an acute ischemic
stroke is intravenous thrombolysis (IVT). However, there are some limitations and …

Background and Purpose—Recently, 5 randomized controlled trials demonstrated the
benefit of endovascular therapy compared with intravenous tissue-type plasminogen …

Background Recent clinical trials have demonstrated the efficacy of mechanical
thrombectomy in acute ischemic stroke. Aims To determine the cost-effectiveness, value of …

Background: Early reperfusion is critical for favorable outcomes in acute ischemic stroke
(AIS). Stent retrievers lead to faster and more complete reperfusion than previous …

Objectives Endovascular mechanical thrombectomy is an effective but expensive therapy for
acute ischaemic stroke with proximal anterior circulation occlusion. This study aimed to …

Objective: To evaluate the cost-effectiveness of adding endovascular thrombectomy to
standard care in patients with acute ischemic stroke. Methods: The cost-effectiveness …

Purpose Although good evidence exists regarding the clinical effectiveness of mechanical
thrombectomy for people with acute ischaemic stroke, cost-effectiveness should also be …

Background The RESILIENT trial demonstrated the clinical benefit of mechanical
thrombectomy in patients presenting acute ischemic stroke secondary to anterior circulation …